Anti-vitronectin single-chain variable fragment targeting the hemopexin-like domain decreases age-related macular degeneration indicators in ex vivo models of the retinal pigment epithelium
Kim, J. W.; Meyer, S.; Lopez, B.; Faynus, M.; Johnson, L. V.; Hemmati, H.; Clegg, D. O.; Min, H.
Show abstract
Vitronectin is a prominent constituent of the extracelluar matrix (ECM) that plays a key role in inflammation by regulating cell adhesion, migration, and complement activation. Together with other inflammatory biomarkers, lipids, and hydroxyapatite, an ECM component, vitronectin, accumulates in abnormal deposits and drusen associated with age-related macular degeneration (AMD). Using an engineered polypeptide (VnHX) containing the hexmopexin-like domain (HX) of vitronectin, we found that the HX domain directly promotes hydroxyapatite (HAP) accumulation. Next, we screened humanized single-chain variable fragments (scFvs) against vitronectin that inhibit the interaction between VnHX and HAP, leveraging the binding of VnHX to HAP. We then tested these scFvs for their ability to block Vn-containg deposits secreted by stem cell-derived retinal pigment epithelium (RPE). In this in vitro drusen model, treatment with the anti-vitronectin antibodies decreased vitronectin accumulation. Furthermore, the antibody treatment led to decreased accumulation of C5b-9 and clusterin, indicating alterations in the complement pathway and cellular stress. These results support that vitronectin has a functional role drusen accumulation and possibly in AMD progression. Vitronectin would be a novel, promising therapeutic target for AMD.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genetic and cellular basis of impaired phagocytosis and photoreceptor degeneration in CLN3 disease. 96%
- The sialome of the retina, alteration in age-related macular degeneration (AMD) pathology and potential impacts on Complement Factor H 94%
- Topical administration of novel FKBP12 ligand MP-004 improves retinal function and structure in retinitis pigmentosa models. 94%
Similar papers in this journal
- Start codon disruption with CRISPR/Cas9 prevents murine Fuchs' endothelial corneal dystrophy 94%
- Reserpine maintains photoreceptor survival in retinal ciliopathy by resolving proteostasis imbalance and ciliogenesis defects 94%
- Human iPSC-derived Microglial Cells Integrated into Mouse Retina and Recapitulated Features of Endogenous Microglia 93%
Similar papers in this journal
- Self-organization, quality control, and preclinical studies of human iPSC-derived retinal sheets for tissue-transplantation therapy 94%
- An in vitro tumorigenesis model based on live cell-generated oxygen and nutrient gradients 92%
- The small molecule ML233 is a direct inhibitor of tyrosinase function 92%
Similar papers in this journal
Similar papers in this journal
- Introduced chemokine gradients guide transplanted and regenerated retinal neurons toward their natural position in the retina 94%
- Corticosteroids prevent pathological angiogenesis yet compromise reparative vascular remodeling in the retina 94%
- Occludin Acts as a Dynein Adaptor Regulating Permeability and Collateral Angiogenesis 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.